Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review

The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)

(2017) Sang-Ryol Ryu et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices

(2016) Bruce M Robinson et al.   LANCET

SP310FUNCTIONAL IRON DEFICIENCY AFFECTS PLATELET INCREASE AFTER HIGH-DOSE ERYTHROPOIETIN STIMULATING AGENTS THETAPY AMONG PREDIALYSIS CKD PATIENTS

(2016) Sayoko Yonemoto et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Anemia and risk for cognitive decline in chronic kidney disease

(2016) Manjula Kurella Tamura et al.   BMC Nephrology

Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia

(2016) Daniel Eriksson et al.   BMC Nephrology

Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study

(2015) Tae Yamamoto et al.   Clinical and Experimental Nephrology

Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study

(2015) Soichiro Iimori et al.   NEPHROLOGY

Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity-matched analysis

(2015) Kiyoto Koibuchi et al.   NEPHROLOGY

FP577PERITONEAL DIALYSIS IN ELDERLY PATIENTS DECREASES THE BURDEN OF DIALYSIS TREATMENT EXPENDITURE IN JAPAN

(2015) Makoto Hiramatsu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Low Levels of Serum Ferritin Lead to Adequate Hemoglobin Levels and Good Survival in Hemodialysis Patients

(2015) Chie Ogawa et al.   AMERICAN JOURNAL OF NEPHROLOGY

Erythropoietin Resistance Index and the All-Cause Mortality of Chronic Hemodialysis Patients

(2014) Masayuki Okazaki et al.   BLOOD PURIFICATION

Responsiveness to erythropoiesis-stimulating agents and renal survival in patients with chronic kidney disease

(2014) Michio Kuwahara et al.   Clinical and Experimental Nephrology

Prognostic Impact of Chronic Kidney Disease and Anemia at Admission on In-Hospital Outcomes After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

(2014) Jun Shiraishi et al.   International Heart Journal

Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients

(2014) Takahiro Kuragano et al.   KIDNEY INTERNATIONAL

Prevalence of Anemia in Chronic Kidney Disease in the United States

(2014) Melissa E. Stauffer et al.   PLoS One

Associations between renal impairment and anemia in older, rural Japanese men: the Nagasaki Island study

(2014) Yuji Shimizu et al.   Journal of Physiological Anthropology

Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patients

(2013) Michio Kuwahara et al.   Clinical and Experimental Nephrology

Anaemia management and mortality risk in chronic kidney disease

(2013) Walter H. Hörl   Nature Reviews Nephrology

The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: a single-center cohort study

(2012) Junichi Ishigami et al.   Clinical and Experimental Nephrology

Disappearance of Association in Diabetic Patients on Hemodialysis between Anemia and Mortality Risk: The Japan Dialysis Outcomes and Practice Pattern Study

(2012) Masaaki Inaba et al.   NEPHRON CLINICAL PRACTICE

Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study

(2011) Tadao Akizawa et al.   Clinical and Experimental Nephrology

Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin

(2010) Takeshi Hasegawa et al.   KIDNEY INTERNATIONAL

2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

(2010) Yoshiharu Tsubakihara et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Mild anemia is frequent and associated with micro- and macroangiopathies in patients with type 2 diabetes mellitus

(2010) Hiroyuki Ito et al.   Journal of Diabetes Investigation

Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literature

(2010) Floortje E. van Nooten et al.   JOURNAL OF MEDICAL ECONOMICS

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Prevalence of anemia according to stage of chronic kidney disease in a large screening cohort of Japanese

(2009) Kentaro Kohagura et al.   Clinical and Experimental Nephrology

Influence of atherosclerosis on the relationship between anaemia and mortality risk in haemodialysis patients

(2008) K. Maekawa et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS

(2008) T. Akizawa et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION